Clinical trials
Recruiting Phase 1 Mesothelioma, Malignant trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 1 |
| Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 1 |
| Ascentage Pharma Group Inc. | 1 |
| Context Therapeutics Inc. | 1 |
| David Bartlett, MD | 1 |
| Erasmus Medical Center | 1 |
| IDEAYA Biosciences | 1 |
| Nurix Therapeutics, Inc. | 1 |
| SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 1 |
| Suzhou Maximum Bio-tech Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma, Malignant | 12 |
| Neoplasm Metastasis | 4 |
| Pleural Effusion, Malignant | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Ovarian Epithelial | 2 |
| Carcinoma, Transitional Cell | 2 |
| Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Recurrence | 2 |
| Carcinoma, Neuroendocrine | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.